Source: EduBourse

univ-lille: UCB and University of Lille anti-tau immunotherapy research highlighted in prestigious internatio...

Research demonstrates potential for anti-tau immunotherapy in treatment of Alzheimer's and other tau-driven diseases including progressive supranuclear palsy (PSP) Findings, combined with previous in vitro research, highlight important differences betwee

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
5.0-10K
Regis Bordet's photo - President of ULille

President

Regis Bordet

CEO Approval Rating

90/100

Read more